NICE methods review, UK Life Sciences Strategy and the life sciences industry: lessons for Australia
Brendan Shaw “We must balance ensuring the NHS gets the best value, delivering improved patient access and promoting innovation. These proposals mean we meet expectations to introduce effective products as soon as possible while maintaining a world-leading robust approach.” - Professor Gillian Leng CBE, Chief Executive, NICE “That’s why we are setting out our new Life Sciences Vision to bottle the formula we have developed to tackle COVID and improve health outcomes fo